Metal carboxylate complexes possess different carboxylate coordination modes, e.g. monodentate, bidentate, and bridging bidentate. Five Zn(II) complexes were prepared and characterized in order to examine their coordination modes in addition to their biological activity. The syntheses were started by preparation of [Zn(ibup)2(H2O)2] (1). Then, different nitrogen-donor ligands reacted with 1 to produce [Zn(ibup)2(2-ampy)2] (2), [Zn(ibup)(2-ammethylpy)] (3), [Zn(ibup)(2,2′-bipy)] (4), and [Zn2(ibup)4(2-methylampy)2] (5) (ibup = ibuprofen, 2-ampy = 2-aminopyridine, 2-ammethylpy = 2-aminomethylpyridine, 2,2′-bipy = 2,2′-bipyridine, 2-methylampy = 2-(methylamino)pyridine). IR, 1H NMR, 13C{1H}-NMR and UV–vis spectroscopies were used for characterization. The crystal structures of 2 and 5 were determined by single-crystal X-ray diffraction. Investigation of in vitro antibacterial activities for the complexes against Gram-positive (Micrococcus luteus, Staphylococcus aureus and Bacillus subtilis) and Gram-negative (Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis) bacteria were done using agar well-diffusion method. Complex 1 showed antibacterial activity against Gram-positive bacteria. Complexes 2 and 3 did not exhibit antibacterial activity. Complex 4 showed antibacterial activity and was chosen for further studies to determine the inhibition zone diameter for different concentrations and to set the minimum inhibitory concentration. The antibacterial activity against most of the bacteria was minimized as a result of the complexation of zinc ibuprofen with 2,2′-bipy in 4.
A new bis(pyrazolylpyridine) ligand (H2L) has been prepared to form functional [Fe2(H2L)3]4+ metallohelicates. Changes to the synthesis yield six derivatives, X@[Fe2(H2L)3]X(PF6)2⋅xCH3OH (1, x=5.7 and X=Cl; 2, x=4 and X=Br), X@[Fe2(H2L)3]X(PF6)2⋅yCH3OH⋅H2O (1 a, y=3 and X=Cl; 2 a, y=1 and X=Br) and X@[Fe2(H2L)3](I3)2⋅3 Et2O (1 b, X=Cl; 2 b, X=Br). Their structure and functional properties are described in detail by single‐crystal X‐ray diffraction experiments at several temperatures. Helicates 1 a and 2 a are obtained from 1 and 2, respectively, by a single‐crystal‐to‐single‐crystal mechanism. The three possible magnetic states, [LS–LS], [LS–HS], and [HS–HS] can be accessed over large temperature ranges as a result of the structural nonequivalence of the FeII centers. The nature of the guest (Cl− vs. Br−) shifts the spin crossover (SCO) temperature by roughly 40 K. Also, metastable [LS–HS] or [HS–HS] states are generated through irradiation. All helicates (X@[Fe2(H2L)3])3+ persist in solution.
1 January 2015 in European Journal of Medicinal Chemistry
Identifying and quantifying the individual factors affecting the temperature and properties of the spin crossover in transition metal complexes is a challenging task, because many variables are involved. While the most decisive factor is the crystal field imparted by ligands around the active metal center, some less common actors are intramolecular steric repulsions or non-covalent interactions. A series of three Fe(II) complexes of 1,3bpp derivatives of (2-(pyrazol-1-yl)-6-(1H-pyrazol-3-yl)pyridine) have been prepared and characterized crystallographically to probe these effects: [Fe(1,3bpp)2](ClO4)2 (1), [Fe(met1,3bpp)2](ClO4)2 (2) and [Fe(dimet1,3bpp)2](ClO4)2 (3). The ligands exhibit none, one or two methyl substituents on the pyrazol-1-yl heterocycle. These groups exert a dramatic effect on the SCO temperature in the solid state, and, most significantly, in solution (with TSCO (3) > TSCO (1) > TSCO (2)). Extensive DFT calculations have unveiled the origin of these effects which lie in the intramolecular non-covalent or steric interactions rather than resulting from crystal field effects.